A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study
- Resource Type
- Article
- Source
- In
Gynecologic Oncology September 2017 146(3):554-559 - Subject
- Language
- ISSN
- 0090-8258